Main

related bits

0

processing priority

3

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-01-18 01:26:02

expired found date

-

created at

2024-06-06 08:27:30

updated at

2025-12-29 06:05:48

Domain name statistics

length

10

crc

53430

tld

840

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

75976557

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

19409

mp size raw text

3696

mp inner links count

3

mp inner links status

20 (imported)

Open Graph

title

Trautec US

description

Building a global leading company to expand the application of recombinant collagen SRHC products for medical regeneration, medical aesthetics and medicine.

image

site name

author

updated

2025-12-16 23:18:50

raw text

Trautec US - The most compatible recombinant collagen SRHC animal-free Home About Product News & Events Contact CN 中文 SRHC Recharge Regenerate Renewal Learn More The industrial configuration has once more been enhanced, with L Catterton and CITIC Lyon Capital spearheading the investment in Trautec's Series B funding round. Trautec secures U.S. PCT patent authorization for "Recombinant Type XVII Collagen: Preparation Method and Application" visit our booth at these upcoming events/shows Homogolous with human collagen Introducing SRHC Type III: The Epitome of Recombinant Human Collagen Compatibility We take immense pride in unveiling SRHC Type III, a groundbreaking achievement in the realm of recombinant human collagen. Meticulously engineered using proprietary synthetic technology and cultivated through advanced bio-fermentation processes, SRHC Type III stands as a testament to our commitment to setting new industry standards in compatibility and biocompatibility...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medycyna (36)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

2

text cyrillic

0

text characters

3061

text words

493

text unique words

272

text lines

49

text sentences

24

text paragraphs

11

text words per sentence

20

text matched phrases

3

text matched dictionaries

3

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

15

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-01-24 01:25:56

sitemap process date

2024-11-08 15:01:44

sitemap first import date

-

sitemap last import date

-